GOT-IT (Guidelines on Target Assessment for Innovative Therapeutics) - Target Assessment Resource Centre - Events


Events 2020

ONLINE-BIH Lecture (11.12.2020)
BIH Lecture Series: "Frontiers in Translational Medicine - Scientific and Structural Challenges"
Angelika Fretzen, PhD, MBA: "Keys to Successful Technology Translation by Entrepreneurs in Academia and Biotech"

Experiences from both shores of the Charles River, MA

BIH Lecture Series | Frontiers in Translational Medicine – Scientific and Structural Challenges
The successful translation of innovative technologies into new enterprises requires factors that are both internal and external to the entrepreneurial team. The Wyss Institute for Biologically Inspired Engineering at Harvard University has developed a unique model that draws the most innovative ideas from blue-sky research in leading academic groups throughout the Boston area, and then de-risks these technologies to create impactful product opportunities with the guidance of industry experts both inside and outside the walls of the Institute. The thoughtful assembly of a diverse team of many fully engaged stakeholders is equally important as the product development process in bringing a technology forward into the hands of patients or other end-users.

Combining entrepreneurial experience with her leadership responsibilities at the Wyss Institute, Dr. Fretzen will elaborate on the Wyss’ model and explore what she sees as the keys to the successful translation of technologies that have the ambitious goal of measurable positive impact on society.

Angelika Fretzen, PhD, MBA, is a product development executive with over 20 years of experience in academia and biotech.

After training as organic chemist and earning a diploma from the Julius Maximilians Universität in Würzburg followed by a doctoral degree from the Université de Genève in Switzerland, Dr. Fretzen completed a postdoctoral fellowship with Gregory L. Verdine at Harvard University, where she witnessed the take-off and trajectory of the biotech sector in one of the leading innovation hubs in the world. Dr. Fretzen took the opportunity to join a team of young entrepreneurs at Ironwood Pharmaceuticals where she became Vice President of Chemical & Pharmaceutical Development, key inventor and member of the R&D team that successfully launched Linzess, for the treatment of gastrointestinal diseases. She then joined Catabasis as Senior Vice President of Pharmaceutical Development, overseeing the progression of edasalonexent from discovery to Phase 3 clinical development for the treatment of Duchenne Muscular Dystrophy. In 2019, Dr. Fretzen became part of the Executive Leadership Team at the Wyss Institute, assuming product and business development responsibilities, and she is currently transitioning into the role of the Institute’s Chief Operating Officer.


Due to the current situation and to contain the corona virus, this BIH Lecture will be held Online via GoToMeeting. To participate in the lecture, please register here.

Login via GoToMeeting

Please note that login link and access code are not sent out immediately after your registration. You will receive both shortly before the lecture, most likely the evening before. You have the following possibilities to participate:

  • You can download the GoToMeeting App (please do so before the lecture starts!)
  • You can link in via the Browser (preferably Chrome)
  • You can dial in by telephone (you will receive the dial-in number after your registration)

For security reasons, please login to GoToMeeting with your full name and institution (preferably in abbreviated form) and please do not use an pseudonyms or alias names. In order to save online capacity and to keep the transmission stable, we kindly ask you to turn off your camera and microphone immediately after joining the session and during the lecture.

Discussion via Chat Room

The discussion will be held via the chat room function of GoToMeeting. If you would like to join this discussion, please type in your question into the chat room and send it to “organizer”. The moderator will pose your question to the speaker or arrange a dialogue if applicable.


The BIH Online-Lecture will be recorded for the documentation on our website. If you do not wish to be recorded, please make sure your camera and microphone are turned off at any time.

REWARD - EQUATOR Conference 2020 (20. - 22.02.2020)

Luisenstraße 58/59
10117 Berlin

Hosted by the BIH QUEST Center, the topic of the conference is: Sharing Strategies for Research Improvement - Challenges and opportunities for Improvement for Ethics Committees and Regulators, Publishers, Institutions and Researchers, Funders – and Methods for measuring and testing Interventions. A more detailed timetable for the programme can be found here.

Experimental Biology 2020 (05.03.2020)

San Diego Convention Center (SDCC)
111 West Harbor Drive
San Diego
California 92101

Experimental Biology Symposium Series 2020. Changing Research Practice: How Can I Make My Research More Reproducible ? - Session Time: 1:30 PM – 3:00 PM - Session Location: Ballroom 28B, San Diego Convention Center - Session Chair(s): Tracey L. Weissgerber. A more detailed timetable for the programme can be found here.

ENRIO’s First Congress on Research Integrity Practice (05. - 07.10.2020)

Aalto University
Building Dipoli
Otakaari 24
02150 Espoo

The ENRIO2020 Congress is aimed for research integrity officers, research directors, science funding organizations, research networks, and other professionals in the field of research integrity and research ethics, members of ethics committees, and university teachers and researchers. The Congress presents an excellent opportunity to keep abreast of the latest thinking and insights on current issues and best practice in the field of research integrity, and expand your network of colleagues across Europe. A more detailed timetable for the programme can be found here.

Events 2019

British Pharmacological Society Meeting 2019 (15. - 17.12.2019)

Michael Parnham presented the goals and concept of the GOT-IT project at the British Pharmacological Society Meeting 2019 in Edinburgh. Parnham M, Emmerich CH, Martinez-Gamboa L, Hofmann M, Bespalov A, Dirnagl U. GOT-IT - Guidelines on Target Assessment for Innovative Therapeutics. (Abstract / Poster)

2nd GOT-IT Target Validation Meeting (07.10.2019)

Charité - Universitätsmedizin Berlin
Charité Campus Mitte CCM
Berliner Medizinhistorisches Museum
The Lecture Hall Ruin
Charitéplatz 1
10117 Berlin

On 07.10.2019 the second meeting of GOT-IT will take place in Berlin (Charité Campus Mitte, Berliner Medizinhistorisches Museum, The Lecture Hall Ruin).

6th World Conference on Research Integrity (02.06.2019)

Christoph Emmerich presented the goals and concept of the GOT-IT project at the 6th World Conference on Research Integrity in Hong Kong. The GOT-IT poster presentation was awarded the 2nd prize by the 6th WCRI committee.

Emmerich CH, Martinez-Gamboa L, Gerlach B, Bespalov A, Hofmann M, Bonin-Andresen M, Schendel P, Parnham M, Dirnagl U. GOT-IT - Guidelines on Target Assessment for Innovative Therapeutics. (Abstract / Poster)